Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial [18F]Fluorothymidine (FLT)PET/CT as a Biomarker of Therapeutic Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer

NCT02274038 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02274038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02274038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial [18F]Fluorothymidine (FLT)PET/CT as a Biomarker of Therapeutic Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2015
Completion date
July 31, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer, starting pemetrexed based therapy, unresectable cancer